SeaStar Medical 10-Q: Equity Line, Warrants Detailed
Ticker: ICUCW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1831868
| Field | Detail |
|---|---|
| Company | Seastar Medical Holding CORP (ICUCW) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, warrants, equity-line-of-credit, 10-Q
TL;DR
SeaStar Medical 10-Q: Equity line with Lincoln Park active, warrants detailed. Financing in focus.
AI Summary
SeaStar Medical Holding Corp. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position, including details on common stock and warrants. A significant event mentioned is the Equity Line of Credit Purchase Agreement with Lincoln Park Capital Fund, LLC, involving regular purchases of common stock, with a subsequent event noted on April 26, 2025.
Why It Matters
This filing provides insight into SeaStar Medical's ongoing financing activities and capital structure, which are crucial for its operational and growth strategies.
Risk Assessment
Risk Level: medium — The company's reliance on equity financing and the details surrounding its warrants suggest potential dilution and financial risk.
Key Numbers
- N/A — Revenue (Specific revenue figures for the quarter are not detailed in the provided text.)
- N/A — Net Income/Loss (Specific net income or loss figures for the quarter are not detailed in the provided text.)
- N/A — Cash Flow (Specific cash flow figures for the quarter are not detailed in the provided text.)
Key Players & Entities
- SeaStar Medical Holding Corp (company) — Filer
- Lincoln Park Capital Fund, LLC (company) — Financing partner
- 20250331 (date) — Reporting period end date
- April 26, 2025 (date) — Subsequent event date
FAQ
What is the total amount of common stock purchased by Lincoln Park Capital Fund, LLC under the Equity Line of Credit Purchase Agreement as of March 31, 2025?
The provided text does not specify the total amount purchased, only that regular purchases occurred and a subsequent event on April 26, 2025, is noted.
What is the valuation methodology used for the 'EquityClassifiedWarrantsMember' and 'LiabilityClassifiedWarrantsMember' as of March 31, 2025?
The filing mentions 'us-gaap:FairValueInputsLevel3Member' and 'us-gaap:MeasurementInputPriceVolatilityMember' in relation to warrants, suggesting Level 3 inputs and volatility are considered in fair value measurements.
What was the nature of the 'JanuaryTwentyTwentyFourRegisteredDirectOfferingMember'?
The filing indicates this was a 'us-gaap:PrivatePlacementMember' involving 'us-gaap:CommonStockMember' on January 26, 2024.
Are there any significant changes in the company's debt structure reported in this 10-Q?
The provided text does not detail changes in debt structure; it focuses on equity financing and warrants.
What is the current status of SeaStar Medical's 'PublicStockholdersWarrantsMember' as of March 31, 2025?
The filing categorizes these as 'EquityClassifiedWarrantsMember' as of March 31, 2025, indicating they are accounted for as equity instruments.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding SeaStar Medical Holding Corp (ICUCW).